Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the tr...

Read More

ADIL Performance At-A-Glance

RISK EFFICIENCY

-0.74

ADIAL PHARMACEUTICALS, INC.'s risk efficiency is -0.74, which is poor. By comparison, the S&P500 is -0.5.

DSCORE

8.97%

ADIAL PHARMACEUTICALS, INC.'s dScore is 8.97% , which is more volatile than the S&P500 (2.74%).

Increasing slightly over the past 4 weeks.

GROWTH

-80.40%

ADIAL PHARMACEUTICALS, INC. has shrunk by -80.4% over the past year.  By comparison, the S&P500 has lost -12.78%.

Increasing slightly over the past 4 weeks.